Unmasking Tandem Site Interaction in Human Acetylcholinesterase. Substrate Activation with a Cationic Acetanilide Substrate
- 16 April 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 42 (18) , 5438-5452
- https://doi.org/10.1021/bi027065u
Abstract
Acetylcholinesterase (AChE) contains a narrow and deep active site gorge with two sites of ligand binding, an acylation site (or A-site) at the base of the gorge, and a peripheral site (or P-site) near the gorge entrance. The P-site contributes to catalytic efficiency by transiently binding substrates on their way to the acylation site, where a short-lived acyl enzyme intermediate is produced. A conformational interaction between the A- and P-sites has recently been found to modulate ligand affinities. We now demonstrate that this interaction is of functional importance by showing that the acetylation rate constant of a substrate bound to the A-site is increased by a factor a when a second molecule of substrate binds to the P-site. This demonstration became feasible through the introduction of a new acetanilide substrate analogue of acetylcholine, 3-(acetamido)-N,N,N-trimethylanilinium (ATMA), for which a = 4. This substrate has a low acetylation rate constant and equilibrates with the catalytic site, allowing a tractable algebraic solution to the rate equation for substrate hydrolysis. ATMA affinities for the A- and P-sites deduced from the kinetic analysis were confirmed by fluorescence titration with thioflavin T as a reporter ligand. Values of a >1 give rise to a hydrolysis profile called substrate activation, and the AChE site-specific mutant W86F, and to a lesser extent wild-type human AChE itself, showed substrate activation with acetylthiocholine as the substrate. Substrate activation was incorporated into a previous catalytic scheme for AChE in which a bound P-site ligand can also block product dissociation from the A-site, and two additional features of the AChE catalytic pathway were revealed. First, the ability of a bound P-site ligand to increase the substrate acetylation rate constant varied with the structure of the ligand: thioflavin T accelerated ATMA acetylation by a factor a(2) of 1.3, while propidium failed to accelerate. Second, catalytic rate constants in the initial intermediate formed during acylation (EAP, where EA is the acyl enzyme and P is the alcohol leaving group cleaved from the ester substrate) may be constrained such that the leaving group P must dissociate before hydrolytic deacylation can occur.Keywords
This publication has 20 references indexed in Scilit:
- Engineering of a monomeric and low‐glycosylated form of human butyrylcholinesteraseEuropean Journal of Biochemistry, 2002
- Involvement of Deacylation in Activation of Substrate Hydrolysis by Drosophila AcetylcholinesterasePublished by Elsevier ,2001
- Interaction Kinetics of Reversible Inhibitors and Substrates with Acetylcholinesterase and Its Fasciculin 2 ComplexPublished by Elsevier ,2001
- Effects of mutations of active site residues and amino acids interacting with the Ω loop on substrate activation of butyrylcholinesteraseBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2001
- The X-ray Structure of a Transition State Analog Complex Reveals the Molecular Origins of the Catalytic Power and Substrate Specificity of AcetylcholinesteraseJournal of the American Chemical Society, 1996
- Asp70 in the Peripheral Anionic Site of Human ButyrylcholinesteraseEuropean Journal of Biochemistry, 1996
- Kinetics of butyrylcholinesterase in reversed micelles under high pressureBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1995
- Acetylcholinesterase-catalyzed hydrolysis of anilides: acylation reaction dynamics and intrinsic chemical transition-state structuresJournal of the American Chemical Society, 1987
- Ellman's reagent: 5,5′-dithiobis(2-nitrobenzoic acid)—a reexaminationAnalytical Biochemistry, 1979
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961